Paper23174751
Personalized treatment of uveal melanoma.
Damato B and 1 other. Eye (Lond), 2013. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Personalized treatment of uveal melanoma. Papers, record 23174751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23174751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Patient-Centered Care | Major topic |
| Uveal Neoplasms | Major topic |
| Counseling | |
| England | |
| Family | |
| Humans | |
| Uveal Melanoma |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11642372 | Vitreoretinal surgery and endoresection in high posterior choroidal melanomas. | Retina | 2001 | https://conductscience.org/library/papers/11642372 | PubMed |
| 2 | 22042014 | Local resection of uveal melanoma. | Dev Ophthalmol | 2012 | https://conductscience.org/library/papers/22042014 | PubMed |
| 3 | 22744385 | Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. | Eye (Lond) | 2012 | https://conductscience.org/library/papers/22744385 | PubMed |
| 4 | 22042010 | Treatment selection for uveal melanoma. | Dev Ophthalmol | 2012 | https://conductscience.org/library/papers/22042010 | PubMed |
| 5 | 21658465 | Estimating prognosis for survival after treatment of choroidal melanoma. | Prog Retin Eye Res | 2011 | https://conductscience.org/library/papers/21658465 | PubMed |
| 6 | 16111578 | Proton beam radiotherapy of iris melanoma. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/16111578 | PubMed |
| 7 | 16946742 | Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy. | Eye (Lond) | 2007 | https://conductscience.org/library/papers/16946742 | PubMed |
| 8 | 18653597 | Endoresection in high posterior choroidal melanomas: long-term outcome. | Br J Ophthalmol | 2008 | https://conductscience.org/library/papers/18653597 | PubMed |
| 9 | 22079972 | Differences in uveal melanomas between men and women from the British Isles. | Eye (Lond) | 2012 | https://conductscience.org/library/papers/22079972 | PubMed |
| 10 | 22521086 | Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. | Ophthalmology | 2012 | https://conductscience.org/library/papers/22521086 | PubMed |
| 11 | 9602614 | Endoresection of choroidal melanoma. | Br J Ophthalmol | 1998 | https://conductscience.org/library/papers/9602614 | PubMed |
| 12 | 16029800 | Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/16029800 | PubMed |
| 13 | 10070510 | Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. | Eye (Lond) | 1998 | https://conductscience.org/library/papers/10070510 | PubMed |
| 14 | 21746991 | Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. | Arch Ophthalmol | 2011 | https://conductscience.org/library/papers/21746991 | PubMed |
| 15 | 21029286 | Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma. | Health Expect | 2011 | https://conductscience.org/library/papers/21029286 | PubMed |
| 16 | 15990248 | Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15990248 | PubMed |
| 17 | 9544628 | Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases. | Ophthalmology | 1998 | https://conductscience.org/library/papers/9544628 | PubMed |
| 18 | 22522723 | A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial. | Eye (Lond) | 2012 | https://conductscience.org/library/papers/22522723 | PubMed |
| 19 | 18653590 | Choroidal melanoma endoresection, dandelions and allegory-based medicine. | Br J Ophthalmol | 2008 | https://conductscience.org/library/papers/18653590 | PubMed |
| 20 | 15913907 | Local tumor control after 106Ru brachytherapy of choroidal melanoma. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15913907 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42303830 | GWAS meta-analysis provides new insights into uveal melanoma risk. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42303830 | PubMed |
| 41632384 | Uveal melanoma survival prediction system: a multi-center database study. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/41632384 | PubMed |
| 41151907 | Clinical Applications of Artificial Intelligence in Uveal Melanoma. | Anticancer Res | 2025 | https://conductscience.org/library/papers/41151907 | PubMed |
| 40723158 | The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723158 | PubMed |
| 40213305 | Surgical treatment of uveal melanoma: Exoresection versus endoresection. | Taiwan J Ophthalmol | 2025 | https://conductscience.org/library/papers/40213305 | PubMed |
| 39918656 | Artificial intelligence with ChatGPT 4: a large language model in support of ocular oncology cases. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/39918656 | PubMed |
| 39548476 | Anxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France - protocol of a prospective observational mixed-method study. | BMC Psychiatry | 2024 | https://conductscience.org/library/papers/39548476 | PubMed |
| 38347180 | Local anaesthesia under sedation versus general anaesthesia for brachytherapy-treated patients with uveal melanoma: A patient-reported outcome study. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/38347180 | PubMed |
| 37752341 | Prevalence, temporal course and risk factors for phantom eye symptoms in uveal melanoma. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/37752341 | PubMed |
| 37174076 | Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37174076 | PubMed |
| 36672282 | Ocular Complications of Radiotherapy in Uveal Melanoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672282 | PubMed |
| 35941183 | Predictors of emotional distress in uveal melanoma survivors: a systematic review. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/35941183 | PubMed |
| 35348598 | Vascular Lakes in Uveal Melanoma and Their Association With Outcome. | Transl Vis Sci Technol | 2022 | https://conductscience.org/library/papers/35348598 | PubMed |
| 34850324 | Fear of cancer recurrence and adverse cancer treatment outcomes: predicting 2- to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivors. | J Cancer Surviv | 2023 | https://conductscience.org/library/papers/34850324 | PubMed |
| 34453274 | Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients. | J Behav Med | 2022 | https://conductscience.org/library/papers/34453274 | PubMed |
| 34298647 | Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298647 | PubMed |
| 34085131 | Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications. | Insights Imaging | 2021 | https://conductscience.org/library/papers/34085131 | PubMed |
| 34015800 | Two 11-Years Periods Statistics and Trends of Enucleation and Evisceration. | J Craniofac Surg | 2021 | https://conductscience.org/library/papers/34015800 | PubMed |
| 33871760 | Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors. | J Cancer Surviv | 2022 | https://conductscience.org/library/papers/33871760 | PubMed |
| 33066024 | High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33066024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23174751
GET https://conductscience.org/api/papers/v1/23174751/references?page=2